These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 29750642

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Parathyroid hormone control survey to determine inter-method and inter-lab variations in Japan.
    Kakuta T, Kato H, Komaba H, Akizawa T, Japanese PTH Control Survey Committee.
    Ther Apher Dial; 2011 Jun; 15 Suppl 1():50-5. PubMed ID: 21595853
    [Abstract] [Full Text] [Related]

  • 24. Inter-method variability in PTH measurement: implication for the care of CKD patients.
    Souberbielle JC, Boutten A, Carlier MC, Chevenne D, Coumaros G, Lawson-Body E, Massart C, Monge M, Myara J, Parent X, Plouvier E, Houillier P.
    Kidney Int; 2006 Jul; 70(2):345-50. PubMed ID: 16788691
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Evaluation of a chemiluminescence immunoassay for the determination of intact parathyroid hormone using the ADVIA Centaur.
    Amal L, Bergmann P.
    Clin Lab; 2004 Jul; 50(11-12):695-702. PubMed ID: 15575312
    [Abstract] [Full Text] [Related]

  • 30. Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism.
    Kaczirek K, Prager G, Riss P, Wunderer G, Asari R, Scheuba C, Bieglmayer C, Niederle B.
    Arch Surg; 2006 Feb; 141(2):129-34; discussion 134. PubMed ID: 16490888
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Assays for parathyroid hormone and their use in patients with end-stage renal disease.
    Goodman WG.
    Blood Purif; 2003 Feb; 21(1):118-23. PubMed ID: 12596757
    [Abstract] [Full Text] [Related]

  • 33. Parathyroid hormone: new assays, new receptors.
    Martin KJ, Akhtar I, González EA.
    Semin Nephrol; 2004 Jan; 24(1):3-9. PubMed ID: 14730504
    [Abstract] [Full Text] [Related]

  • 34. Primary hyperparathyroidism with a low-normal, atypical serum parathyroid hormone as shown by discordant immunoassay curves.
    Lafferty FW, Hamlin CR, Corrado KR, Arnold A, Shuck JM.
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3826-9. PubMed ID: 16849415
    [Abstract] [Full Text] [Related]

  • 35. Technical and clinical characterization of the Bio-PTH (1-84) immunochemiluminometric assay and comparison with a second-generation assay for parathyroid hormone.
    Inaba M, Nakatsuka K, Imanishi Y, Watanabe M, Mamiya Y, Ishimura E, Nishizawa Y.
    Clin Chem; 2004 Feb; 50(2):385-90. PubMed ID: 14684623
    [Abstract] [Full Text] [Related]

  • 36. Comparison of the Elecsys PTH(1-84) assay with four contemporary second generation intact PTH assays and association with other biomarkers in chronic kidney disease patients.
    Tan K, Ong L, Sethi SK, Saw S.
    Clin Biochem; 2013 Jun; 46(9):781-6. PubMed ID: 23384535
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Switching between parathormone (PTH) assays: the impact on the diagnosis of renal osteodystrophy.
    Bekő G, Butz H, Berta K, Tislér A, Olajos F, Vásárhelyi B, Patócs A.
    Clin Chem Lab Med; 2013 Jun; 51(6):1251-6. PubMed ID: 23241601
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Critical issues of PTH assays in CKD.
    Komaba H, Goto S, Fukagawa M.
    Bone; 2009 Apr; 44(4):666-70. PubMed ID: 19159701
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.